Inventor · disambiguated record
Yashwant M. Deo
Also filed as: DEO YASHWANT M
22 granted patents·7 pending applications·3,453 citations·filing 1995–2018
97Inventor score
Top patents by PatentIndex Score
29 records- 0199US8017114B2Human CTLA-4 antibodies and their usesMEDAREX INC·Filed 2009·Granted Sep 13, 2011·199 cites·33 claims
- 0299US7605238B2Human CTLA-4 antibodies and their usesMEDAREX INC·Filed 2001·Granted Oct 20, 2009·353 cites·32 claims
- 0399US6984720B1Human CTLA-4 antibodiesMEDAREX INC·Filed 2000·Granted Jan 10, 2006·897 cites·14 claims
- 0499US5922845ATherapeutic multispecific compounds comprised of anti-Fcα receptor antibodiesMEDAREX INC·Filed 1996·Granted Jul 13, 1999·448 cites·24 claims
- 0598US8784815B2Human CTLA-4 antibodies and their usesKORMAN ALAN J·Filed 2012·Granted Jul 22, 2014·40 cites·29 claims
- 0698US8318916B2Human CTLA-4 antibodies and their usesKORMAN ALAN J·Filed 2011·Granted Nov 27, 2012·49 cites·38 claims
- 0798US5837243ATherapeutic compounds comprised of anti-Fc receptor antibodiesMEDAREX INC·Filed 1996·Granted Nov 17, 1998·545 cites·18 claims
- 0897US6270765B1Therapeutic compounds comprised of anti-Fc receptor antibodiesMEDAREX INC·Filed 1998·Granted Aug 7, 2001·215 cites·9 claims
- 0996US6303755B1Therapeutic multispecific compounds comprised of anti-FCA receptor antibodiesMEDAREX INC·Filed 1999·Granted Oct 16, 2001·116 cites·17 claims
- 1095US7387776B2Human monoclonal antibodies against CD30MEDAREX INC·Filed 2003·Granted Jun 17, 2008·70 cites·15 claims
- 1193US6410690B1Therapeutic compounds comprised of anti-Fc receptor antibodiesMEDAREX INC·Filed 1995·Granted Jun 25, 2002·91 cites·17 claims
- 1293US6395272B1Therapeutic compounds comprised of anti-Fc receptor antibodiesMEDEREX INC·Filed 1998·Granted May 28, 2002·127 cites·6 claims
- 1393US6365161B1Therapeutic compounds comprised of anti-FC receptor binding agentsMEDAREX INC·Filed 1999·Granted Apr 2, 2002·113 cites·20 claims
- 1492US6682928B2Cells expressing anti-Fc receptor binding componentsMEDAREX INC·Filed 1998·Granted Jan 27, 2004·89 cites·24 claims
- 1585US7560534B2Molecular conjugates comprising human monoclonal antibodies to dendritic cellsCELLDEX RES CORP·Filed 2001·Granted Jul 14, 2009·26 cites·8 claims
- 1684US8222032B2Cell lines and methods for producing proteinsPARKER STEPHEN H·Filed 2009·Granted Jul 17, 2012·10 cites·13 claims
- 1784US6193966B1Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodiesMEDERAX INC·Filed 1997·Granted Feb 27, 2001·48 cites·29 claims
- 1881US8088377B2Human monoclonal antibodies against CD30KELER TIBOR·Filed 2008·Granted Jan 3, 2012·4 cites·10 claims
- 1981US7563876B2Human monoclonal antibodies to dendritic cellsCELLDEX THERAPEUTICS INC·Filed 2001·Granted Jul 21, 2009·11 cites·1 claims
- 2075US8142790B2Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cellsDEO YASHWANT M·Filed 2008·Granted Mar 27, 2012·2 cites·8 claims
- 2172US2014234331A1Human ctla-4 antibodies and their usesMEDAREX LLC·Filed 2014·Application pending·0 cites
- 2271US2019119384A1Human ctla-4 antibodies and their usesSQUIBB & SONS LLC·Filed 2018·Application pending·0 cites
- 2363US7316812B2Cells expressing anti-Fc receptor binding componentsCELLDEX THERAPEUTICS INC·Filed 2004·Granted Jan 8, 2008·0 cites·25 claims
- 2463US2016257753A1Human ctla-4 antibodies and their usesSQUIBB & SONS LLC·Filed 2016·Application pending·0 cites
- 2557US2005090001A1Cell lines and methods for producing proteinsFiled 2004·Application pending·0 cites
- 2656US9095626B2Monoclonal antibodies to dendritic cellsDEO YASHWANT M·Filed 2012·Granted Aug 4, 2015·0 cites·15 claims
- 2754US2001014328A1Therapeutic multispecific compounds comprised of anti-Fcalpha receptor antibodiesMEDERAX INC·Filed 2001·Application pending·0 cites
- 2851US2006159658A1Methods of treating disease with glycosylated interferonAVIGENICS INC·Filed 2006·Application pending·0 cites
- 2950US2016024192A1Molecular conjugates comprising human monoclonal antibodies to dendritic cellsCELLDEX THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →